GLP-1 Therapies Research Papers

2 weeks ago • The lancet. Psychiatry

Starting GLP-1 drugs and the risk of psychiatric hospital visits in US adults with schizophrenia and type 2 diabetesGLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data.

🥇 Top 1% JournalObservational Study

5 days ago • Frontiers in endocrinology

Comparing new blood sugar drugs and their effects on heart and kidney health in people with type 2 diabetes and heart failureNetwork and pairwise meta-analysis of the effects of novel hypoglycemic agents on cardiorenal outcomes in patients with type 2 diabetes and heart failure.

🎖️ Top 10% JournalSystematic Review

1 week ago • International journal of molecular sciences

Clinical Outcomes of GLP-1 Receptor Agonist Treatment in Cancer PatientsGLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes.

📖 Top 20% JournalSystematic Review

1 week ago • Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Use of Glucagon-like Peptide-1 Receptor Agonists and Risk of Lymphedema After Breast Cancer SurgeryGlucagon-like peptide-1 receptor agonist use and risk of postmastectomy lymphedema in breast cancer survivors: a multicenter real-world cohort study.

📖 Top 20% JournalMulticenter Study

1 week ago • Nutrients

Changes in Bile Acid Processing and Nutrient-Triggered Hormone Responses After Two Types of Digestive Weight-Loss Surgery: RYGB Versus SADI-SChanges in Bile Acid Metabolism and Nutrient-Stimulated Hormone Responses After Malabsorptive Metabolic Surgery: RYGB Versus SADI-S.

🎖️ Top 10% JournalObservational Study

1 week ago • Nutrients

Effects of GLP-1 Receptor Drugs on Thinking Skills in Adults at Risk for Alzheimer's DiseaseImpact of GLP-1 Receptor Agonists on Cognitive Performance in Adults at Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

🎖️ Top 10% JournalSystematic Review

1 week ago • Medical sciences (Basel, Switzerland)

Skin Side Effects Linked to Semaglutide, Liraglutide, and TirzepatideCutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review.

🎖️ Top 10% JournalSystematic Review

1 week ago • Frontiers in medicine

Liraglutide's effects on blood pressure and kidney function in type 2 diabetes with kidney damageEffects of liraglutide on blood pressure and renal function in patients with type 2 diabetic nephropathy: a meta-analysis of randomized controlled trials.

📖 Top 20% JournalSystematic Review

1 week ago • European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

Comparing drugs that target both GIP and GLP-1 receptors versus only GLP-1 receptor in patients having knee or hip replacement surgeryDual GIP/GLP-1 receptor agonist versus selective GLP-1 receptor agonist in patients undergoing primary total knee or hip arthroplasty.

📖 Top 30% JournalComparative Study

2 weeks ago • Frontiers in endocrinology

Comparing CagriSema and Semaglutide 2.4 mg alone for weight loss in adults with overweight or obesity, with or without type 2 diabetesCagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis.

🎖️ Top 10% JournalSystematic Review

2 weeks ago • Frontiers in cardiovascular medicine

GLP-1 Treatments for Obesity-Linked Heart Failure with Preserved Pumping Function: A Review Including Related Heart and Metabolic StudiesGLP-1-Based therapies for obesity-related heart failure with preserved ejection fraction: an umbrella review incorporating broader heart failure and cardiometabolic evidence.

📖 Top 20% JournalSystematic Review

2 weeks ago • Nature communications

How eating different forms of chickpeas affects small intestine metabolism and gut bacteriaEffect of dietary chickpea structures on the small intestine metabolome and microbiome: a randomised crossover trial.

🥈 Top 2% JournalRandomized Controlled Trial

2 weeks ago • Frontiers in cardiovascular medicine

📖 Top 20% JournalSystematic Review

3 weeks ago • Frontiers in endocrinology

Expert Recommendations for Long-Term Use of GLP-1 Medicines in Treating ObesityLong-term GLP-1 receptor agonist therapy in obesity: expert panel recommendations for good clinical practice.

🎖️ Top 10% JournalPractice Guideline

3 weeks ago • Clinical obesity

Weight loss after stomach surgery compared to tirzepatide treatment in a minority group with severe obesityWeight-Loss Outcomes After Sleeve Gastrectomy Versus Tirzepatide in a Minority Cohort With Severe Obesity: Results From a Propensity Score Matched Cohort.

📖 Top 30% JournalComparative Study

4 days ago • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Metabolic, hormone, and reproductive changes linked to GLP-1 receptor drugs in women with high male hormones and insulin resistanceMetabolic, hormonal, and reproductive effects of GLP-1 receptor agonizts in hyperandrogenic insulin-resistant women: a systematic review.

📖 Top 30% JournalSystematic Review

2 weeks ago • Acta neuropsychiatrica

Effects of GLP-1 single-acting drugs on reward processing in animal studiesEffects of glucagon-like peptide-1 (GLP-1) mono-agonists on reward processing in animal models: a systematic review.

📖 Top 20% JournalSystematic Review

1 week ago • Medicine

Effectiveness and safety of GLP-1 drugs in people with fatty liver disease linked to metabolism problems and liver inflammationEfficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis.

📖 Top 50% JournalSystematic Review

3 weeks ago • Medicine

Short-term benefits and side effects of semaglutide plus dapagliflozin in type 2 diabetes patients with kidney diseaseShort-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease.

📖 Top 50% JournalObservational Study

1 week ago • Archives of osteoporosis

Effects of GLP-1 receptor therapy on bone health in adults with overweight or obesitySkeletal effects of GLP-1 receptor agonist therapy in adults with overweight or obesity: a systematic review.

📖 Top 20% JournalSystematic Review

2 weeks ago • Signal transduction and targeted therapy

Kidney-protective effects of polyethylene glycol-loxenatide in people with type 2 diabetesReal-world renoprotective effects of polyethylene glycol-loxenatide in type 2 diabetes: a multicenter, ambispective cohort study.

🥇 Top 1% JournalMulticenter Study

3 weeks ago • Current cardiology reports

Differences in Use of Two Diabetes Drugs and a Fair Approach to Heart, Kidney, and Metabolic CareDisparities in GLP-1RA and SGLT2i Uptake: a Systematic Review and an Equity-First Framework for Cardiovascular-Kidney-Metabolic Care.

📖 Top 20% JournalSystematic Review

3 weeks ago • Cell metabolism

UBT251, a new treatment activating three hormone receptors, tested in adults with overweight or obesity in a phase 2 trialUBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with overweight or obesity: A multicenter, randomized phase 2 trial.

🥇 Top 1% JournalArticle

4 weeks ago • Sleep & breathing = Schlaf & Atmung

GLP-1 receptor drugs and their effects on obstructive sleep apnea: a combined analysis of clinical trialsGLP-1 receptor agonists for obstructive sleep apnea: a meta-analysis of randomized controlled trials.

📖 Top 30% JournalSystematic Review

4 weeks ago • Drug design, development and therapy

Risk of New Dementia in COVID-19 Survivors with Type 2 Diabetes Using GLP-1 Receptor Agonists Compared to DPP-4 InhibitorsGLP-1 Receptor Agonists Versus DPP-4 Inhibitors and Incident Dementia Risk in COVID-19 Survivors with Type 2 Diabetes: A Target Trial Emulation Study.

📖 Top 20% JournalComparative Study

1 month ago • Drug design, development and therapy

Clinical outcomes after sepsis in type 2 diabetes patients previously treated with GLP-1 receptor agonists versus SGLT2 inhibitorsPrior Use of GLP-1 Receptor Agonists versus SGLT2 Inhibitors and Clinical Outcomes After Sepsis in Patients with Type 2 Diabetes: A Propensity Score-Matched Cohort Study.

📖 Top 20% JournalComparative Study

2 weeks ago • International journal of molecular sciences

How Activating GLP-1, GIP, and Glucagon Receptors May Link Obesity and Brain DegenerationGLP-1, GIP, and Glucagon Receptor Agonism at the Obesity-Neurodegeneration Interface: A Narrative Review.

📖 Top 20% JournalArticle

2 weeks ago • Nutrients

GLP-1 Treatments and Muscle Health in Obesity: Body Weight, Muscle Strength, and Muscle Loss OutcomesGLP-1-Based Pharmacotherapies and Skeletal Muscle Health in Obesity: A Narrative Review of Body Composition, Muscle Function, and Sarcopenia-Related Outcomes.

🎖️ Top 10% JournalArticle

3 weeks ago • Frontiers in endocrinology

The full treatment journey of incretin and multi-receptor drugs beyond their effectivenessBeyond efficacy: the treatment lifecycle of incretin and multi-receptor agonists.

🎖️ Top 10% JournalArticle

6 days ago • BMC cardiovascular disorders

Comparing heart-related side effect patterns of GLP-1 receptor drugs using FDA reportsComparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database.

📖 Top 30% JournalComparative Study

← prevpage 1 of 16next →